Results 41 to 50 of about 28,317 (294)

Prevalence and incidence of nodding syndrome and other forms of epilepsy in onchocerciasis-endemic areas in northern Uganda after the implementation of onchocerciasis control measures

Infectious Diseases of Poverty, 2020
Background Around 2007, a nodding syndrome (NS) epidemic appeared in onchocerciasis-endemic districts of northern Uganda, where ivermectin mass distribution had never been implemented.
Nolbert Gumisiriza, F. Mubiru, J. S. Siewe Fodjo, Martin Mbonye Kayitale, A. Hotterbeekx, R. Idro, Issa Makumbi, T. Lakwo, B. Opar, J. Kaducu, J. Wamala, R. Colebunders   +11 more
semanticscholar   +1 more source

Update on the current status of onchocerciasis in Cote d’Ivoire following 40 years of intervention: Progress and challenges [PDF]

, 2018
Background Onchocerciasis control in Côte d’Ivoire started with aerial insecticide spraying in 1974 and continued with community directed treatment with ivermectin (CDTi) from 1992 to the present.
Aba, Elvis, Brika, Pierre, Fischer, Peter U, King, Christopher L, Kouakou, Marie-Madeleine, Kouakou, Roger, Koudou, Benjamin G, Meite, Aboulaye, Ouattara, Allassane F, Weil, Gary J, Yeo, Souleymane   +10 more
core   +3 more sources

Onchocerciasis Prevalence among Persons with Epilepsy in an Onchocerciasis Hypo-Endemic Area in the Democratic Republic of Congo: A Cross-Sectional Study

Pathogens, 2021
A high epilepsy prevalence has been reported in onchocerciasis meso- and hyper-endemic regions in sub-Saharan Africa, including in the Democratic Republic of Congo (DRC). We investigated whether onchocerciasis-associated epilepsy can also be suspected in
An Hotterbeekx, Kristien Verdonck, Deby Mukendi, Jean-Roger Lilo-Kalo, Pascal Lutumba, Marleen Boelaert, Liselotte Hardy, Barbara Barbé, Jan Jacobs, Emmanuel Bottieau, Robert Colebunders   +10 more
doaj   +1 more source

“Rapid-Impact Interventions”: How a Policy of Integrated Control for Africa's Neglected Tropical Diseases Could Benefit the Poor [PDF]

, 2005
Controlling seven tropical infections in Africa would cost just 40 cents per person per year, and would permanently benefit hundreds of millions of ...
Alan Fenwick, Commission for Africa, David H Molyneux, Peter J Hotez, The Lancet, The Lancet, UNAIDS, UNAIDS, What Works Working Group, What Works Working Group, World Bank, World Health Organization, World Health Organization, World Health Organization and Government of Mexico, World Health Organization, The Stop TB Partnership   +14 more
core   +4 more sources

The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (2) pre-control endemicity levels and estimated number infected

Parasites & Vectors, 2014
Background The original aim of the African Programme for Onchocerciasis Control (APOC) was to control onchocerciasis as a public health problem in 20 African countries.
Honorat GM Zouré, Mounkaila Noma, Afework H Tekle, Uche V Amazigo, Peter J Diggle, Emanuele Giorgi, Jan HF Remme   +6 more
doaj   +1 more source

The World Health Organization 2030 goals for onchocerciasis: Insights and perspectives from mathematical modelling [version 1; peer review: 2 approved]

Gates Open Research, 2019
The World Health Organization (WHO) has embarked on a consultation process to refine the 2030 goals for priority neglected tropical diseases (NTDs), onchocerciasis among them.
NTD Modelling Consortium Onchocerciasis Group
doaj   +1 more source

Human Onchocerciasis: Modelling the Potential Long-term Consequences of a Vaccination Programme. [PDF]

PLoS Neglected Tropical Diseases, 2015
BACKGROUND:Currently, the predominant onchocerciasis control strategy in Africa is annual mass drug administration (MDA) with ivermectin. However, there is a consensus among the global health community, supported by mathematical modelling, that ...
Hugo C Turner, Martin Walker, Sara Lustigman, David W Taylor, María-Gloria Basáñez   +4 more
doaj   +1 more source

Nodding syndrome research, lessons learned from the NSETHIO project

Cambridge Prisms: Global Mental Health, 2019
Background.Until recently, nodding syndrome (NS) was considered as a mysterious disease of unknown etiology. A link between onchocerciasis and epilepsy was suspected for a long time.
D. Geelhand de Merxem, J. N. Siewe Fodjo, S. Menon, A. Hotterbeekx, R. Colebunders   +4 more
doaj   +1 more source

Moxidectin: an oral treatment for human onchocerciasis

Expert Review of Anti-Infective Therapy, 2020
Introduction Moxidectin is a milbemycin endectocide recently approved for the treatment of human onchocerciasis. Onchocerciasis, earmarked for elimination of transmission, is a filarial infection endemic in Africa, Yemen, and the Amazonian focus ...
Philip Milton, Jonathan I D Hamley, M. Walker, M. Basáñez   +3 more
semanticscholar   +1 more source

The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (1) priority areas for ivermectin treatment

Parasites & Vectors, 2014
Background The African Programme for Onchocerciasis Control (APOC) was created to control onchocerciasis as a public health problem in 20 African countries. Its main strategy is community directed treatment with ivermectin.
Mounkaila Noma, Honorat GM Zouré, Afework H Tekle, Peter AI Enyong, Bertram EB Nwoke, Jan HF Remme   +5 more
doaj   +1 more source